Longeveron LGVN
NASDAQ LGVN
$2.58 -0.01 (-0.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Longeveron (LGVN) Non Operating Interest Expenses (2020 - 2022)

Updated

Longeveron (LGVN) recorded Non Operating Interest Expenses of $1.4 million in Q4 2022, compared with $1,000 a year earlier.

Analysis

Longeveron (LGVN) Non Operating Interest Expenses (2020 - 2022) Analysis & Trends

Starting with Q3 2020, Longeveron's Non Operating Interest Expenses history includes 6 quarters.

  • Across earlier years, Non Operating Interest Expenses came in at $4,000 in FY2021 (-42.9%) and $7,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 281.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -435.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 247.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Longeveron 7.81 Mn -32.00 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.40 Mn
Dec 31, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 2,000.00
Dec 31, 2020 3,000.00
Sep 30, 2020 4,000.00
API Access

Longeveron Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LGVN&period=max&api_key=YOUR_API_KEY